Managed Access Program of Venglustat in Pediatric and Adult Patients With Type 3 Gaucher Disease (GD3).

NCT07675031 · clinicaltrials.gov ↗
AVAILABLE
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi